Methylenedioxymethamphetamine-induced suppression of interleukin-1 and tumour necrosis factor- is not mediated by serotonin

By Connor T.J.   Dennedy M.C.   Harkin A.   Kelly J.P.  

European Journal of Pharmacology, Vol. 418, Iss. 1, 2001-04 ,pp. : 147-152

Elsevier

Access to resources Recommend Favorite

Tumour necrosis factor and interleukin 1 signalling: do MAPKK kinases connect it all?

By Eder J.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 9, 1997-10 ,pp. : 319-322

Elsevier

Access to resources Recommend Favorite

The Effects of Calcitriol Therapy on Serum Interleukin-1, Interleukin-6 and Tumour Necrosis Factor-α Concentrations in Post-menopausal Patients with Osteoporosis

By Inanir A   Özoran K   Tutkak H   Mermerci B  

The Journal of International Medical Research, Vol. 32, Iss. 6, 2004-11 ,pp. : 570-582

Field House Publishing

Access to resources Recommend Favorite

Interleukin-1 , interleukin-6, tumour necrosis factor- and interferon- released by a viral infection and an aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytes

By Bleau A.-M.   Maurel P.   Pichette V.   Leblond F.   du Souich P.  

European Journal of Pharmacology, Vol. 473, Iss. 2, 2003-07 ,pp. : 197-206

Elsevier

Access to resources Recommend Favorite

Azelnidipine, a New Long-acting Calcium-channel Blocker, Inhibits Tumour Necrosis Factor-α-induced Monocyte Chemoattractant Protein-1 Expression in Endothelial Cells

By Matsui T   Yamagishi S   Nakamura K   Inoue H  

The Journal of International Medical Research, Vol. 34, Iss. 6, 2006-11 ,pp. : 671-675

Field House Publishing

Access to resources Recommend Favorite